In the final months of last year, deal professionals and analysts arrived at a consensus forecast for 2025. After a year of gradually increasing volume, improved macro-conditions combined with pent-up seller demand would lead to a land rush of quality deals coming to market.
I was part of this consensus. The land rush isn’t happening – at least not yet.
Deal activity remains sluggish. One measure I cited back in the fall was the U.S. Conference Board’s Expectations Index, which by definition is more forward-looking than the more widely cited confidence index. As of October 31, the expectations index had risen to 89 from 73 in March of 2024. As of the end of January, the index had fallen back to 83.9 (a value of 80 signals the expectation of a recession).
“What a time to be a $10-million EBITDA commercial landscaper.”
We can all list the contributing factors beyond softer consumer outlook – stubborn inflation, reduced prospect of interest rate cuts, supply chain disruptions, uncertainty over tariffs and regulations.
Maybe we should have seen more of that coming, but deal people are nothing if not eternal optimists.
What actually seems to be occurring in early 2025 is a continuation of conditions that characterized the market in 2024. Macro-economic and sectoral challenges are weighing most heavily on businesses in manufacturing, distribution and third-party logistics. As firms in these categories hold back from sale, professional, commercial and residential service firms have come to dominate the market.
A private equity friend recently called to commiserate about how light the new-deal pipeline seems to be for industrial properties. “But,” he said, “what a time to be a $10-million EBITDA commercial landscaper.”
It’s there to see in the numbers.
We turned to GF Data, the M&A data tracking firm I co-founded and ran until 2022, and cut the data to focus on: (1) Manufacturing (MFR) and business services (BS), the two categories that comprise about 60 percent of the data set; (2) Three time periods representing pre-pandemic conditions (2018-19), the heart of pandemic-era dynamics (2020-22) and a return to normalized conditions (2023-24); (3) Deals between $25 and $250 mm TEV; and (4) The useful distinction GF Data makes between selling businesses with above-average financial performance (AAFP) and others (NON).
There are comparatively fewer high-performing manufacturers in-market – this is the scarcity driving valuation.
Here’s what we see: First, overall valuations have stabilized, but with significant differences between the two industries. The overall mark for business services is conventionally .75-1.0x greater than for manufacturing. While that relationship holds at the aggregate level, this masks two quite different dynamics within the AAFP and non-AAFP subsets. AAFP manufacturers have shaved the spread to .1x. Among the non-AAFPs, the spread has widened to 1.2x.
Second, there are comparatively fewer high-performing manufacturers in-market – this is the scarcity driving valuation. GF Data recorded a completed deal explosion in 2021, coming out of deep Covid, followed by a drop off in 2023 and a steady resurgence in 2024. Across all three periods, manufacturing deals account for about 60 percent of the combined MFR/BS deal volume, but a steadily declining share of AAFPs.
Third, non-AAFP Business Service firms are also getting some lift from being in market at a time when buyers are starved for product.
The “Quality Premium” is GF Data’s long-standing measure of the gap in valuation between AAFPs and non-AAFPs, based on TTM EBITDA margins and revenue growth rates along with a review of industry category and other deal characteristics.
Better performers commanded premiums in the 20-25% range in both business services and manufacturing prior to Covid. The smaller cohort of manufacturing AAFPs continue to receive an average pricing differential in that range. In business services, though, the premium has dropped to 3.9%.
Dissatisfaction with the current exit environment will continue to be one factor driving the proliferation of private equity continuation vehicles.
The buyer who opts not to pay 12x for that mythical top performer still wants to put money to work. So, they may be paying 8x for a property that would be valued at 7x in less of a seller’s market.
2025 DO-OVER TAKEAWAYS
(1) The macro factors creating uncertainty will take some time to resolve.
(2) It is a great time to be that $10 million landscaper, but it’s also great to be one of the handful of industrial businesses not subject to uncertainty over regulation, government spending or trade policy. Defense and medical technology come to mind as two sectors with well-defended niches.
(3) We tell GVC clients that when buyers are asked to value a company based on a prospective turn rather than proven performance, there is always a discount. It is just a matter of how much. However, the imperative many financial buyers face to put money to work will continue to exert downward pressure on that discount. Earnouts and seller financing – widely disparaged but useful price bridging mechanisms — will remain in vogue, particularly for smaller transactions in this tier of the market.
(4) Dissatisfaction with the current exit environment will continue to be one factor driving the proliferation of private equity continuation vehicles (CVs).
(5) CVs are not a scratch for every itch. If there is an uptick in new product in 2025, it will be evident first among financial buyers who need to respond to holding period expectations of their investors. Individual/family business owners who can afford to wait, generally do.
*****
About the Author
Andy Greenberg is CEO of Greenberg Variations Capital, a mergers & acquisitions advisory firm based in suburban Philadelphia devoted to one-off or targeted transactions. Mr. Greenberg was founder and CEO of GF Data©, the M&A data tracking service, prior to its acquisition by the Association for Corporate Growth in 2022.
For more information, visit www.greenbergvariations.com.